CER − evolution or revolution?

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.630, 2011-01, pp. : 5-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug pricing and competition policy: evolution or revolution?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 340, 2001-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

CER: what factors guide healthcare decision making?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Molecular-Targeting Revolution Advances into Renal Cancer: Is Sutent® the New Gold Standard for Metastatic Disease?

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 7, 2006-07 ,pp. : 8-10

Adis International

Access to resources Recommend Favorite

Hypertension Revolution or Just Hype?: First Renin Inhibitor Close to the Market

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 4, 2006-01 ,pp. : 7-9

Adis International

Access to resources Recommend Favorite

The Evolution of the Periodic Safety Update Report: Still Fit for Purpose?

By Blum Michael D.  

Pharmaceutical Medicine, Vol. 24, Iss. 3, 2010-06 ,pp. : 141-143

Adis International

Access to resources Recommend Favorite